Completed Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer NCT03377556 Conditions ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation, +18 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States Anchorage Associates in Radiation Medicine — Anchorage, Alaska, United States Anchorage Radiation Therapy Center — Anchorage, Alaska, United States Alaska Breast Care and Surgery LLC — Anchorage, Alaska, United States View all 1157 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Olaparib In Metastatic Breast Cancer NCT03344965 Conditions ATM Gene Mutation, BRIP1 Gene Mutation, Breast Diseases, +14 more Locations University of Alabama at Birmingham — Birmingham, Alabama, United States University of California, San Francisco — San Francisco, California, United States University of Chicago — Chicago, Illinois, United States Indiana University — Indianapolis, Indiana, United States View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details